Marizyme

Marizyme is a company listed under the stock ticker MRZM (US).

View the org chart displaying its 12 main executives

Most searched biographies at Marizyme

• David Barthel, Chief Executive Officer
• Michael Stewart, Director
• Vithalbhai Dhaduk, Chairman of the Board

Create your alert
to follow the executive moves at Marizyme.

Marizyme has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Marizyme

Social media about Marizyme

• Marizyme on Wikipedia, Google News & Yahoo Finance
• Marizyme on LinkedIn, Twitter & YouTube

Contact by email its executives including David Barthel

Call Marizyme at +1 732...

View the org chart

Register to receive your alert

Report an error